Skip to content
In English |
En español
Search
Prostate Cancer Prevention (PDQ®)
Last Modified:
08/26/2008
Cancer Incidence in Study of Clark: Randomized Trial of Selenium
Cancer Site
Selenium
Placebo
Hazard Ratio
P
value
Lung
17
31
.56
.05
Prostate
13
35
.35
.001
Colorectal
8
19
.39
.03
Head/neck
6
8
.77
.64
Bladder
8
6
1.27
.66
Esophageal
2
6
.30
.14
Breast
9
3
2.95
.11
Other carcinoma
5
9
.54
.27
Total carcinoma
59
104
.54
<.001
Melanoma
8
8
.92
.87
Leukemia
8
5
1.50
.48
Other noncarcinoma
3
3
.99
.99
Total noncarcinomas
19
16
1.16
.65
Total cancers
77
119
.61
<.001
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute